A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia

NCT07243379 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

495

Enrollment

INDUSTRY

Sponsor class

Conditions

Clinical Characteristics and Treatment Outcomes of Malignant Tumor Cachexia
Multicenter Observational Study

Interventions

DRUG: Nanocrystalline Megestrol Acetate

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.

Collaborators

[object Object]